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Abstract
Background: Despite several previous reports, there are no established procedures for intraoperative management
in moyamoya disease patients requiring cardiac surgery.
Case presentation: Herein, we report the case of a 42-year-old man who was scheduled to undergo mitral valve
plasty for severe mitral regurgitation. He had been diagnosed with moyamoya disease on the onset of cerebral
ischemia at 41 years of age. During the cardiac surgical procedure, the patient was maintained on inhalation anesthesia
with 1 to 1.5 % sevoflurane. Sevoflurane causes cerebral vasodilation followed by increased cerebral blood flow, and
moreover we expected a sevoflurane preconditioning-induced neuroprotective effect. In addition, we used pulsatile
perfusion support to maintain cerebral circulation with intra-aortic balloon pumping during the cardiopulmonary
bypass. We aimed to keep the mean arterial pressure constantly above 70 mmHg. We were able to maintain
regional cerebral oxygen saturation at 80 % of the baseline value, and could not detect the progression of
neurological deficits using follow-up brain single photon emission computed tomography. The patient was
discharged 16 days after admission.
Conclusions: The details of the clinical course of his case will add to our knowledge regarding intraoperative
management options in moyamoya disease patients requiring cardiac surgery. We suggest that pulsatile blood
flow supported by intra-aortic balloon pumping and sevoflurane anesthesia for increasing cerebral blood flow
and for possible neuroprotection may be efficacious for anesthetic management of moyamoya disease patients.
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Background
Moyamoya disease (MMD) is a chronic cerebrovascular
disorder characterized by steno-occlusive changes of the
terminal portion of the internal carotid arteries and the
development of a network of abnormal collateral vessels
[1]. In MMD patients with severe cerebrovascular disorders,
prevention of cerebral ischemia or cerebral hemorrhage dur-
ing cardiac surgery involving cardiopulmonary bypass (CPB)
is extremely difficult because autoregulation of cerebral
blood flow is impaired. Several previous reports have
described intraoperative management in MMD patients
requiring cardiac surgery [2–4], but there is no established
evidence regarding anesthetic agents for maintenance of
general anesthesia, effects of pulsatile perfusion, appropri-
ate cerebral perfusion pressure and arterial carbon dioxide
partial pressure (PaCO2) during CPB.
Herein, we report the successful management of a patient
who had right hemiplegia due to MMD, and who under-
went mitral valve plasty for severe mitral regurgitation
(MR) without deterioration of neurological function.
* Correspondence: kazutomo0815@gmail.com
1Department of Anesthesiology, Tohoku University Hospital, 1-1 Seiryomachi,
Aoba-ku, Sendai 980-8574, Japan
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Saito et al. JA Clinical Reports  (2016) 2:13 
DOI 10.1186/s40981-016-0039-4
Case presentation
A 41-year-old man (height 171.5 cm, body weight 67 kg)
was transferred to the regional medical center due to
right hemiplegia and aphagia. Cerebral magnetic reson-
ance imaging revealed cerebral infarction caused by oc-
clusion of the left middle cerebral artery, while cerebral
magnetic resonance angiography showed the develop-
ment of a network of abnormal collateral vessels. Hence,
the patient was diagnosed with MMD.
Before cerebral revascularization surgery, severe MR
(III/IV) due to the prolapse of the P2 leaflet in the mitral
valve was indicated by transthoracic echocardiography.
Cardiac catheterization indicated elevated pulmonary ar-
terial pressure (PAP) (systolic/diastolic/mean: 86/33/
60 mmHg) and pulmonary capillary wedge pressure
(32 mmHg) at the systemic arterial pressure of 120/83/
102 mmHg. Hence, the patient was admitted to our uni-
versity center for the surgical treatment of MR.
Preoperative single-photon emission computed tomog-
raphy revealed reduced cerebral blood flow in the left
cerebral hemisphere (especially in the external left frontal
cortex; Fig. 1). Neurosurgeons at our center judged that
the patient did not have an indication for cerebral revas-
cularization surgery, which is used to prevent ischemic
complications during the perioperative period of mitral
valve plasty. This was because his left frontal lobe showed
extensive cerebral infarction and no cerebral infarction
symptoms were observed in the right cerebral hemisphere.
Therefore, mitral valve plasty without cerebral revasculari-
zation was chosen.
In the operation room, the patient’s monitoring of
electrocardiogram, oxygen saturation, systemic arterial
pressure via right radial artery catheter, bispectral index,
and regional cerebral oxygen saturation (rSO2) at the
right and left forehead (INVOS™ 5100C, Somanetics,
USA) was initiated before the administration of general
anesthesia. The rSO2 values for the left and right fore-
head were 72 and 81 %, respectively.
General anesthesia was induced by intravenous admin-
istration of 3 mg of midazolam, 0.4 mg of fentanyl, and
50 mg of rocuronium. After tracheal intubation, a trans-
esophageal echocardiography (TEE) probe was inserted.
Then, a central venous catheter and right heart catheter
were inserted via the right internal jugular vein, and
central venous pressure, PAP, cardiac output, and mixed
venous oxygen saturation were measured. The nasopha-
ryngeal temperature and urinary bladder temperature were
also measured.
Before CPB, general anesthesia was maintained by
inhalation of sevoflurane (1–1.5 % of end-tidal concen-
tration). The patient’s PaCO2 was maintained between
38 and 42 mmHg. Intra-aortic balloon pumping (IABP)
was placed at the start of surgery and the augmented
pressure was maintained. The mean arterial pressure was
constantly above 70 mmHg. Before CPB, rSO2 values were
almost above 80 % on both sides (Fig. 2).
During CPB, administration of sevoflurane via the oxy-
genator was also continued because of its cerebrovascular
dilatation activity and potential preconditioning effect
against focal cerebral ischemia. PaCO2 was maintained
between 45 and 50 mmHg, and alpha-stat management
of pH was performed. Hypothermia was induced; the
temperature at the bottom of the nasopharyngeal tem-
prature was 28 °C. We used pulsatile perfusion assist to
maintain cerebral circulation during CPB with IABP. A
decrease in rSO2 was observed 162 min after the initi-
ation of CPB. Our perfusionist increased the CPB pump
flow from 2.2 L/min/m2 to 2.8 L/min/m2 in order to in-
crease cerebral blood flow. Moreover, the concentration
of sevoflurane was increased to 2 %. Yet, rSO2 desatur-
ation (15 % reduction from baseline) was not improved.
We decided to increase the depth-of-anesthesia with an-
other dose of midazolam. After administration of 3 mg of
midazolam, the rSO2 values increased from 67 to 73 % on
the right side and from 71 to 74 % on the left side. During
CPB, the lowest values (and variation) of rSO2 in the left
and right forehead were 71 % (−2 %) and 67 % (−17 %), re-
spectively. Mitral valve plasty was performed as planned.
At the weaning from the CPB, the disappearance of
MR was confirmed by TEE; the weaning was not diffi-
cult. Pulmonary hypertension also improved (PAP was
26/12 mmHg, while systemic arterial pressure was
105/56 mmHg). After CPB, inhalation of sevoflurane
(1–1.5 % of end-tidal concentration) was also continued.
The rSO2 values were almost above 75 % on both sides
and not below the awake rSO2 values (Fig. 2). CPB and
aortic cross-clamping lasted 352 min and 289 min, re-
spectively. On the completion of the surgery, the IABP
Fig. 1 Preoperative single-photon emission computed tomography
scan. A preoperative single-photon emission computed tomography
scan taken at the regional medical center revealed reduced cerebral
blood flow in the left cerebral hemisphere (especially in the external
left frontal cortex)
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was discontinued and sevoflurane administration was
stopped. The patient was transferred to the intensive care
unit with ventilator support under propofol sedation.
On the 1st postoperative day (POD), the patient
was weaned from the ventilator, and the patient did
not complain about any new neurological deficits.
We monitored the rSO2 of his forehead until the
2nd POD and no significant decrease (−20 %) of the
rSO2 values was confirmed. The postoperative course
was uneventful. On the 15th POD, single-photon
emission computed tomography revealed that the
low cerebral blood flow lesions had not changed
(Fig. 3), and the patient was discharged from our
hospital on the 16th POD.
Discussion
We performed anesthesia for mitral valve plasty in a pa-
tient with cerebral infarction due to MMD using pulsa-
tile perfusion of cardiopulmonary bypass with an
assistance of IABP, without exacerbation of neurological
complications.
Anesthetic management of a patient with MMD is ra-
ther challenging, and we have to keep several key-points
in mind. Among them, maintaining normocapnea is most
critical. Hypocapnia would induce brain ischemia and
brain infarction, while hypercapnia would induce vasodila-
tion and hyper-perfusion of the fragile vessels in the brain,
which might cause brain hemorrhage. In patients with
MMD, both vasoconstriction and vasodilation would not
be preferable. That is why keeping normocapnea is quite
important.
During CPB, PaCO2 was maintained between 45 and
50 mmHg with alpha-stat management of pH. This
patient developed MMD not by the onset of cerebral
hemorrhage but by the onset of cerebral infarction.
We regarded that we should avoid hypocapnia or nor-
mocapnea, which would induce cerebral infarction,
rather than hypercapnia, which would induce cerebral
hemorrhage. But, we cannot ignore that hypercapnia
would induce vasodilation and hyper-perfusion of the
fragile vessels in the MMD brain, which might cause
brain hemorrhage.
Usually, extracorporeal circulation is maintained by
non-pulsatile perfusion, and non-pulsatile perfusion can
Fig. 2 Intraoperative regional cerebral oxygen saturation measured by INVOS® and bispectral index. rSO2, regional cerebral oxygen saturation;
BIS, bispectral index; CPB, cardiopulmonary bypass; IABP, intra-aortic balloon pumping
Fig. 3 Postoperative single-photon emission computed tomography
(SPECT) scan. The postoperative SPECT scan obtained from our hospital
revealed that low cerebral blood flow lesions in the left cerebral
hemisphere had not changed compared to the preoperative
SPECT scan
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induce ischemic injury, especially in organs under inad-
equate perfusion [5]. In patients with restricted cerebral
arterial blood supply such as MMD, decreased cerebral
perfusion pressure and non-pulsatile perfusion during
CPB are risk factors for cerebral ischemia.
Kashima et al. [6] reported that high-pressure pulsatile
perfusion assisted by IABP was effective for brain protec-
tion during coronary artery bypass grafting in a MMD pa-
tient. De Buysscher et al. [4] also reported that conversion
from a non-pulsatile flow to a pulsatile flow resulted in a
gradual increase in rSO2 values as opposed to a sudden
decrease in rSO2 in an adult MMD patient undergoing
CPB. In addition, Cheul-Hong et al. [3] reported up to
15 % fluctuations in rSO2 values during cardiac surgery in
an MMD patient who was later discharged from the
hospital without any complications. In pediatric patients
undergoing CPB, pulsatile flow has advantages over non-
pulsatile flow as measured by near-infrared spectroscopy
and transcranial Doppler ultrasound, which may improve
postoperative neurodevelopmental outcomes [7]. Owing
to these previous reports, we selected the pulsatile flow
method supported by IABP in our case and maintained
the mean perfusion pressure above 70 mmHg.
The optimum anesthetic agent for the maintenance of
anesthesia in MMD patients requiring cardiac surgery is
a topic of much debate. Neither inhalational anesthetics
(sevoflurane or isoflurane) nor intravenous anesthetic
(propofol) presents strong clinical evidence for the efficacy
of the outcome. Propofol suppresses cerebral metabolism
and reduces cerebral blood flow [8]. In contrast, sevo-
flurane strongly dilates cerebral vessels and increases
cerebral blood flow [9]. Moreover, several reports de-
scribe sevoflurane preconditioning against myocardial
ischemia-reperfusion injury. Recently, it has been re-
ported that sevoflurane has the potential preconditioning
effect against cerebral ischemia [10], although obvious
preconditioning effect of sevoflurane has not been proved
clinically. In rats with transient cerebral ischemia, sevo-
flurane preconditioning protects mitochondria from
cerebral ischemia-reperfusion injury and ameliorates
long-term neurological deficits [11]. Thus, these prop-
erties may support sevoflurane use over propofol for
intracranial steno-occlusive arterial disease, but choice
of anesthetic in patients with MMD remains an open
question.
A decrease in rSO2 was observed during the CPB. Cur-
rently, rSO2 is considered as the average of arterial oxygen
saturation (SaO2) and internal jugular venous oxygen sat-
uration (SjO2) in the measured region. Several reasons
should be considered for changes of rSO2. It is also known
to be influenced by the skin blood flow [12]. Cutaneous
vasoconstriction induced by vasoconstrictor, such as
phenylephrine and norepinephrine, or hypothermia dur-
ing CPB possibly affects changes of rSO2.
In this case, we increased the pump flow and concen-
tration of sevoflurane to increase cerebral blood flow,
but these interventions were not effective. Secondly, we
deepened the anesthesia level with a supplemental intra-
venous anesthetic. After another administration of mid-
azolam, an improvement in bilateral rSO2 values was
observed. We didn’t know why bilateral rSO2 was im-
proved after administration of an intravenous anesthetic,
but we cannot ignore the possibility that an intravenous
anesthetic decreases the cerebral metabolic rate of oxygen
consumption [7]. When regional cerebral oxygen desatur-
ation continues during sevoflurane general anesthesia in
patients with MMD, it might be efficacious to administer
intravenous anesthetics concurrently. These management
procedures limited the fluctuation of rSO2 values to
within 17 % in our patient, which was nearly equal to that
in a previous study [3], and prevented the development of
cerebral deficits.
Conclusion
Pulsatile flow supported by IABP during CPB had a pos-
sible beneficial effect for brain protection in patients with
restricted cerebral arterial blood supply. Sevoflurane inhal-
ation was continued during CPB with an expectation of its
vasodilatory activity and its potential neuroprotective
effect. We could maintain rSO2 at 80 % of baseline value
during the surgical procedure, and we could not detect
other neurological deficits. But, the further discussion
is warranted whether inhalational anesthetic or intra-
venous anesthetic might be superior for intracranial
steno-occlusive arterial disease. Thus, our case provides
further evidence for the efficacious use of this anesthetic
in MMD patients requiring cardiac surgery.
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